Home > Financial Ratios > CONCORD BIOTECH

CONCORD BIOTECH
Price to Cash Earnings (PCE)

    Back to All Ratios
CONCORD BIOTECH is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for CONCORD BIOTECH
Please provide your vote to see the results

CONCORD BIOTECH Last 5 Year Price to Cash Earnings (PCE) History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   PCE(x) 41.1744.02---

What is the latest Price to Cash Earnings (PCE) ratio of CONCORD BIOTECH ?

The latest Price to Cash Earnings (PCE) ratio of CONCORD BIOTECH is 41.17 based on Mar2025 Consolidated results.
Year Price to Cash Earnings (PCE)
Mar202541.17
Mar202444.02
Mar2023-
Mar2022-
Mar2021-

How is Price to Cash Earnings (PCE) of CONCORD BIOTECH Trending?

Years Price to Cash Earnings (PCE) % Change
Mar2025 41.17
-6.47
Mar2024 44.02
0
Mar2023 0
0
Mar2022 0
0
Mar2021 0 -

Other Financial Ratios of CONCORD BIOTECH


Compare Price to Cash Earnings (PCE) ratio of peers of CONCORD BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
CONCORD BIOTECH ₹12,577.1 Cr -3.6% 3.3% -24.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹427,777.0 Cr -0.1% 4.7% 6.2% Stock Analytics
DIVIS LABORATORIES ₹168,931.0 Cr -1.7% 2.5% 12.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹147,330.0 Cr -1.1% 7.6% 45.4% Stock Analytics
DR REDDYS LABORATORIES ₹109,593.0 Cr -0.4% 6.3% 14.7% Stock Analytics
CIPLA ₹107,112.0 Cr -2.3% 0.3% -8.9% Stock Analytics


CONCORD BIOTECH Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
CONCORD BIOTECH

-3.6%

3.3%

-24.2%

SENSEX

-2.8%

-2%

7.3%


You may also like the below Video Courses